| Literature DB >> 25274738 |
Doan Duy Hai Tran1, Shashank Saran1, Andrew J K Williamson2, Andrew Pierce2, Oliver Dittrich-Breiholz1, Lutz Wiehlmann3, Alexandra Koch1, Anthony D Whetton2, Teruko Tamura4.
Abstract
Transcription of immediate early genes (IEGs) in response to extrinsic and intrinsic signals is tightly regulated at multiple stages. It is known that untranslated regions of the RNA can play a role in these processes. Here we show that THOC5, a member of the TREX (transcription/export) complex, plays a role in expression of only a subset of constitutively active genes, however transcriptome analysis reveals that more than 90% of IEG were not induced by serum in THOC5 depleted cells. Furthermore, THOC5 depletion does not influence the expression of the most rapidly induced IEGs, e.g. Fos and Jun. One group of THOC5 target genes, including Id1, Id3 and Wnt11 transcripts, were not released from chromatin in THOC5 depleted cells. Genes in another group, including Myc and Smad7 transcripts, were released with shortening of 3'UTR by alternative cleavage, and were spliced but export was impaired in THOC5 depleted cells. By interactome analysis using THOC5 as bait, we show that upon stimulation with serum THOC5 forms a complex with polyadenylation-specific factor 100 (CPSF100). THOC5 is required for recruitment of CPSF100 to 3'UTR of THOC5 target genes. These data suggest the presence of a novel mechanism for the control of IEG response by THOC5 via 3'end-processing.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25274738 PMCID: PMC4231767 DOI: 10.1093/nar/gku911
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
PCR primer pair sequences for selected genes
| Gene | Forward primer | Reverse primer | RT-PCR | qRT-PCR | ChIP |
|---|---|---|---|---|---|
| CTATGTTTCTACAGGATTTGTAC | CCATATTCATTTCCTAATGCTTAC | x | |||
| TTCCTGGCAATAGCGTGTTC | TTCAGACCACCTCGACAATG | x | x | ||
| TGTGCCCCAAGAACGTGAC | CCGGGTTGAAGTTGCTGAG | x | x | ||
| TGTGGAAATCTTGCCCTACCT | CCCACTATTCTTCACCGAGTCTA | x | |||
| AGCGAACAACCCTATGAGCAC | TCGTTTGGCTGGGATAACTCG | x | x | ||
| GTACTTGTGTTTGCTTAAACAAAGTAAC | ACCACACATGGGTAAGGACTCA | x | |||
| GCTGCTCAGGATATTCGAGTC | CCAACAGTTGTTAGGTGCTCC | x | |||
| AGGTCGGTGTGAACGGATTTG | TGTAGACCATGTAGTTGAGGTCA | x | |||
| AGCATCTCCCTCACAATTTCCATC | GTTGATTGAGCCTGCTTCACCTC | x | x | ||
| CCAGCCAGTGTCAACACGA | AATGCCGGGAGCTATCTTTCT | x | |||
| CTGAACTCGGAGTCTGAAGT | ACTTTTTTCCTCTTGCCTCCT | x | x | ||
| GGTCACATTTCGTGCTTCTCG | AAACACTCATTCAGGTCGGTAAG | x | |||
| CGCATCTCCCGATCCAGACA | CTGGGTTAAGATCGAAGCTCATCC | x | x | ||
| CAGGAAGGTGACTTTCTGTAATC | CAGCCCTTCCTACTAACCAAG | x | x | ||
| CTGATTATGAACTCTATAATAG | CAAAGTGTTCAAAAATGGTTTATT | x | x | ||
| CCTCCAGAAAAGGCATATTC | GAATGAGGAAGCGCTGATAC | x | x | ||
| TTTGAGCGACGGTAGTGATGC | GAGACTGGAGAAGCGCCTTTG | x | x | ||
| CTGGTCGTAGTTGCTGCCGTAG | GCGTTTTACACCGATGGTCTTTATTTTCC | x | x | ||
| TGCGGAAAACTGGGAGATCTTTAAC | GATTATACTATGGCGAAAGGATCAAC | x | x | ||
| CTGGTCGTAGTTGCTGCCGTAG | CAGTCAAACCAGTTCCGGAG | x | |||
| GCTGTATCGGATGGTCGCATA | CACAGACGGCAAAGCACATT | x | |||
| GCTGGATTTCCTTTGGGCGT | CGCAACATAGGATGGAGAGCA | x | |||
| GGCTTTGGGACTGTAAGCTTCAGC | GGCCCTATTTACATGGGAAAATTGGATAG | x | |||
| GGCTTTGGGACTGTAAGCTTCAGC | GTATTTTTTCCAATTATTTTATTTTTTTCTAAAAAC | x | |||
| GCATTCCTCGGAAGTCAAGAG | CCAGGGGCCAGATAATTCGT | x | |||
| GCTCGCTCGTATGATACTTTGAC | CCTTTCCTCTCTCAAAGCACTAC | x | |||
| GCTCGCTCGTATGATACTTTGAC | CATTCAGCTAGGTGATAACACCCA | x | |||
| CAAGGAGTACCTCAGCCTGG | GGTCAGCAAAAGCACGGTT | x | |||
| GGTGGTACACCGGCCTATG | TCACTGCCGTTGGAAGTCTTG | x | x | ||
| CTGTTTGTGATGTCTGCCAATAG | GAAGATCTGCCTAAGACACGAAAG | x | |||
| CATGGATCTCTCTGCCATCTAC | GAGCCAAAGGTGCAAAACCA | x |
C8orf4 (NM_026931.2): RIKEN cDNA 1810011O10 gene (191nt); c-fos (NM_010234.2): FBJ osteosarcoma oncogene (169 nt); c-jun (NM_010591.2): jun proto-oncogene (243 nt); Dusp2 (NM_010090.2): dual specificity phosphatase 2 (232 nt); Dusp2 (NM_010090.2): dual specificity phosphatase 2 (232 nt); Egr1 (NM_007913.5): early growth response 1 (100 nt); Egr1 (uncleaved) (229 nt); Errfi1 (NM_133753.1): ERBB receptor feedback inhibitor 1 (182 nt); Gapdh (NM_008084.2): glyceraldehyde-3 phosphate dehydrogenase (123 nt); Gapdh (uncleaved) (176 nt); Hes1 (NM_008235.2): hairy and enhancer of split 1 (166 nt); Id1 (NM_010495.3): Inhibitor of DNA binding 1 (203 nt); Id1 (uncleaved) (285 nt); Id3 (NM_008321.2): Inhibitor of DNA binding 3 (202 nt); Id3 (uncleaved) (214 nt); Id3 (3′UTR) (139 nt); Id3 (Promoter) (116 nt); Ier2 (NM_010499.4): immediate early response 2 (173 nt); Ier2 (3′UTR) (174 nt); Ier2 (Promoter) (167 nt); Ier2 (uncleaved) (261 nt); Lif (NM_008501.2): leukemia inhibitory factor (156 nt); Myc (NM_001177352.1): myelocytomatosis oncogene (274 nt); Myc (2071–2245) (175 nt); Myc (2071–2399) (329 nt); Smad7 (NM_001042660.1): SMAD family member 7 (225 nt); Smad7 (3977–4128) (152 nt); Smad7 (3977–4389) (413 nt); Snai1 (NM_011427.2): snail family zinc finger 1 (179 nt); Wnt11 (NM_009519.2): wingless-related MMTV integration site 11 (183 nt); Wnt11 (uncleaved) (215 nt); Zfp36 (NM_011756.4): zinc finger protein 36 (218 nt).
Figure 1.The most rapidly and transiently IEGs are not THOC5 dependent. (A) ERT2Cre THOC5 (flox/flox) MEF cells were treated with tamoxifen (10 μM) for 0–4 days as indicated. Total cell lysates were applied to THOC5- and GAPDH-specific immunoblot. (B and C) ERT2Cre THOC5 (flox/flox) MEF cells were treated with or without tamoxifen for 2 days and prior to incubation in medium without serum for 24 h. The cells were then stimulated with 20% serum for 0, 15, 30 and 60 min. Total RNA was isolated from each sample and semi-quantitative RT-PCR (B) and quantitative (q)RT-PCR (C) were performed. (D) Cells were prepared as described in (B and C) and stimulated with 20% serum for 30 min. RNA was isolated from the nuclear (Nuc) and cytoplasmic (Cyt) fractions and analyzed by RT-PCR. Fractionation quality was measured by immunoblot analysis of THOC5, GAPDH and Histone H3 (Blot). Three independent experiments were performed.
List of THOC5 dependency of serum inducible genes
| Fold reduction of upregulation [group] | Gene symbol |
|---|---|
| <1.3 fold (8 genes) [a] | Aoc3, Btg2, C8orf4, Egr1, Fos,Fosb, Ier2, Zfp36 |
| 1.3–2 fold (18 genes) [b] | Arc, Atf3, Ccno, Cxcl1, Cyr61, Dnajb1, Dusp6, Egr2, Gem, Lsmem1, Nppb, Nr4a1, Rcan1, Rgs16, Sgk1, Skil, Tnfaip3, Trib1 |
| >2 fold (75 genes) [c] | A3galt2, Agbl3, Apobec1, Apol8, Areg, Arl5b, Bhlhe40, C4orf26, Ccrn4l, Cdkn1a, Clcf1, Cmtm4, Csf2, Csf3, Csrnp1, Ctgf, Cul9, Dlx2, Dusp2, Dusp4, Dusp5, Ereg, Errfi1, F3, Fes, Foxc2, Gzmm, Hapln3, Has1, Hbegf, Hes1, Id1, Id2, Id3, Id4, Ier3, Ier5, Ifrd1, Il11, Inhba, Itga5, Junb, Kctd11, Kdm6b, Klf10, Klf9, Klhl21, Lce1f, Lce1h, Lce1i, Lif, Maff, Mmp10, Myc, Myo15a, Nfatc1, Npas4, Pdgfa, Penk, Phlda1, Proca1, Ptgs2, Ret, Serpinb2, Serpine1, Smad7, Snai1, Sox9, Sphk1, Spry4, Tmem88, Tmem95, Usp17l24, Vegfa, Wnt11 |
Accession numbers of each gene described in Supplementary Table S1.
Figure 2.Upon depletion of THOC5, Id1, Id3 and Wnt11 genes were transcribed, but not released from chromatin. (A and B) ERT2Cre THOC5 (flox/flox) MEF cells were treated with or without tamoxifen for 2 days prior to incubation in medium without serum for 24 h. The cells were then stimulated with serum for 0, 1, 2, 4 and 8 h. Total RNA was isolated from each samples and semi-quantitative RT-PCR (A) and quantitative (q)RT-PCR (B) were performed. Primers were located in different exons (Table 1). (C and D) Cells were treated as described in (A) but stimulated with serum for 0.5, 1, 2 and 3 h. Nuclear RNA were isolated and used for RT-PCR. Primers were shown in Table 1. (E) Proteins were extracted from chromatin associated nucleoplasmic and cytoplasmic fractions and were used for LaminAC, GAPDH and Histone H3-specific immunoblot. (F and G) Chromatin associated RNAs were isolated from cells stimulated for 30 min with serum in the presence (Tamoxifen−) or absence (Tamoxifen+) of THOC5 and RT-PCR was performed using the same primers as (C and D). Three independent experiments were performed.
Figure 3.Most IEGs were THOC5 dependent, however the redundant backup pathways partially rescue their upregulation. (A) ERT2Cre THOC5 (flox/flox) MEF cells were treated as described in Figure 2A and semi-quantitative RT-PCR were performed as indicated. Primers were located at different exons (Table 1). (B) Protein and total RNAs were isolated from nuclear and cytoplasmic fractions after 1 or 2 h serum stimulation. Proteins were used for THOC5, Histone H3 or GAPDH-specific immunoblot (Blot) and RNAs were used for RT-PCR as indicated. Three independent experiments were performed.
Figure 4.In the absence of THOC5, processing of Myc or Smad7 genes was partially rescued by a backup pathway but cleaved ∼100 nt upstream from the cleavage site in the presence of THOC5. Schematic presentation of 3′UTR of several IEGs and their accession numbers (italic). Numbers represent nucleotide numbers without poly A. . PAS hexamers (white arrows; numbers represent the first nucleotide of PAS sequence shown in (D). Common PAS hexamers in mouse and human were shown in bold and the UGUA element was shown ‘blue *’. THOC5 dependent cleavage sites are presented by black arrows; THOC5 independent cleavage sites are represented by red arrows. (A) 3′UTR of THOC5 dependent genes, Id1 and Id3. (B) 3′UTR of Myc and Smad 7 genes: both genes contain THOC5 independent cleavage sites. Semi-quantitative Myc and Smad7-specific RT-PCR using up- (P1–P2) or down- stream (P1–P3) of THOC5 independent cleavage sites in the presence or absence of THOC5. (C) THOC5 independent gene (the most rapidly induced IEG). (D) Sequences of PAS hexamers that were indicated (21) in (A–C) as I-IX.
Figure 5.Upon stimulation with serum CPSF100 forms a complex with THOC5. (A and B) ERT2Cre THOC5 (flox/flox) MEF cells were serum starved for 24 h and then stimulated with or without serum for 1 h. Nuclear fractions were isolated using RNase and then precipitated with antibody against THOC5 (A), or CPSF100 (B). Immunoprecipitates were analyzed by THOC5, CPSF100 or CFIm68-specific immunoblot. (C) Mouse NIH3T3 cells were transfected with CPSF100-specific siRNA and control siRNA and cell lysates were used for THOC5 and CSPF100-specific immunoblot. Actin was used as a loading control. (D) Sister cultures from (C) were incubated without serum for 24 h, and then cells were stimulated with serum for 30, 60 or 120 min. RNAs were isolated from each sample and semi-quantitative RT-PCR was performed using Id1, Id3, Ier2, Egr1 and Gapdh-specific primers (Table 1). Three independent experiments were performed and an example of representative data is shown here.
Figure 6.THOC5 is required for recruiting of the CPSF100 to 3′end of THOC5 target gene. pCTAP (cTAP) and pCTAP carrying THOC5 cDNA (TAP-THOC5) were transfected into mouse NIH3T3 cells (Bait: THOC5 (A)), or ERT2 THOC5 (flox/flox) MEF cells were treated with or without tamoxifen for 2 days (Baits: CPSF100 (B), RNApolymerase II (C), or CFIm68 (D)). The cells were then incubated for 24 h in the presence of 20% FCS. After serum starvation for 24 h, cells were stimulated with (+) or without (−) serum for 1 h. After cross-linking by adding formaldehyde, protein and DNA were extracted and the chromatin was sheared by sonication. Cell extracts and binding fractions with streptavidin Sepharose or immunoprecipitates using CPSF100, RNApolymerase II or CFIm68 antibodies or control IgG were analyzed by Id3 (promoter region (-314- -199)and 3′UTR in exon 3 (1433-1571)) and Ier2 (promoter region (-701- -535) and 3′UTR region (1349-1522))-specific PCR (Table 1; ChIP). The promoter region of each gene was described by Zhao etal. (24). Numbers represent nucleotide numbers from the initiation site for each gene. Data represent% input of each PCR reaction. Three independent experiments were performed.